PATENT CLAIM ANALYSIS

Application Number: 15763716
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "017500"]

Abstract:
The present invention relates to an aqueous composition comprising apomorphine or a pharmaceutically acceptable salt or solvate thereof, reduced glutathione (GSH) or a pharmaceutically acceptable salt thereof, and ascorbic acid or a pharmaceutically acceptable salt or derivative thereof, wherein the composition has a pH of about 3 to about 7.4. The aqueous composition according to the invention exhibits superior tolerability and an improved side effect profile, particularly a reduced occurrence of skin nodule formation and panniculitis, when administered subcutaneously. The invention further relates to the composition for use as a medicament, particularly for the treatment of Parkinson's disease.

Claim (Index 5):
The aqueous composition of any one of  claims 1  to  3 , wherein the composition comprises an ascorbic acid/ascorbate buffer, and wherein the composition has a pH of about 5.5.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 90.0
- Lexical Diversity: 1.77419
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14944873', '15809137', '14405913', '13669148', '15789528']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7904647509441299
- 35 USC 102 Novelty (BERT): 0.5170795260134333
- Combined Prediction Score: 0.7631262284510603
- Mean Citation Score: 280.88848
- Max Citation Score: 300.6528600000001
- Similarity Product: 211.4912868501914

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test